Fibrin sealant to reduce blood loss after hip replacement

ISRCTN ISRCTN10862406
DOI https://doi.org/10.1186/ISRCTN10862406
Secondary identifying numbers N0234117607
Submission date
12/09/2003
Registration date
12/09/2003
Last edited
14/04/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr DKA Smart
Scientific

Department of Orthopaedics (AOC)
North Bristol NHS Trust
Southmead Hospital
Westbury-on-Trym
Bristol
BS10 5NB
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titleFibrin sealant to reduce blood loss after hip replacement
Study objectivesDoes fibrin sealant reduce blood loss after primary and revision hip replacement?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSurgery: Hip replacement
InterventionTwo groups: Revision total hip replacement and Primary total hip replacement.
Intervention typeProcedure/Surgery
Primary outcome measureQuantitative estimate of per-operative blood loss, measurement of post-operative blood loss volume via drains, post-operative haemaglobin level, number of patients requiring blood transfusion.
Secondary outcome measuresNot provided at time of registration
Overall study start date01/08/2002
Completion date31/07/2003

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants90
Key inclusion criteriaPrimary hip replacement: 60 patients not on anticoagulant medications, without blood autoantibodies and with pre-operation Hb level >12.5 will be randomised into treatment and control groups.
Revision hip replacement: 30 consecutive patients in treatment group not randomized. Control group will be historical, with information regarding blood loss gained from a retrospective review of notes.
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/08/2002
Date of final enrolment31/07/2003

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

North Bristol NHS Trust
Bristol
BS10 5NB
United Kingdom

Sponsor information

Department of Health (UK)
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website http://www.doh.gov.uk

Funders

Funder type

Government

North Bristol NHS Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan